Location History:
- Los Angeles, CA (US) (2021)
- Adelaide, AU (2022 - 2024)
Company Filing History:
6 out of 597 
5 out of 14 
Years Active: 2021-2025
Title: Janine Bilsborough: Innovator in Inflammatory Bowel Disease Research
Introduction
Janine Bilsborough is a prominent inventor based in Adelaide, Australia. She has made significant contributions to the field of medical research, particularly in the area of inflammatory bowel disease (IBD). With a total of six patents to her name, her work focuses on innovative methods and therapeutic agents that aim to improve patient outcomes.
Latest Patents
Among her latest patents is a method for enriching or amplifying nucleic acids in samples from patients with inflammatory bowel disease. This patent provides methods, systems, and kits for selecting patients for treatment based on the presence of a genotype associated with a positive therapeutic response. The therapeutic agent in this context is often an inhibitor of TL1A activity or expression, such as an anti-TL1A antibody. Another notable patent involves humanized antibodies to TNF-like ligand 1A (TL1A) and their pharmaceutical compositions for treating IBD, including Crohn's Disease and ulcerative colitis.
Career Highlights
Janine has worked with esteemed organizations such as Cedars-Sinai Medical Center and Prometheus Biosciences, Inc. Her experience in these institutions has allowed her to advance her research and contribute to the development of new therapeutic strategies for IBD.
Collaborations
Throughout her career, Janine has collaborated with notable colleagues, including Stephan R. Targan and Jeffry Dean Watkins. These partnerships have further enriched her research and innovation in the field.
Conclusion
Janine Bilsborough is a trailblazer in the realm of inflammatory bowel disease research, with a strong portfolio of patents that reflect her dedication to improving patient care. Her innovative approaches and collaborations continue to make a significant impact in the medical community.